Atkinson Edward Morrow III sold VRTX
February 25, 2025 · Form 4 insider transaction
Atkinson Edward Morrow III sold 1,767 shares of Vertex Pharmaceuticals Incorporated at $480.95 per share, a transaction worth $849.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
1,767
Price
$480.95
Total value
$849.8K
InsiderAtkinson Edward Morrow III
RoleDirector
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateFebruary 25, 2025
Filing dateFebruary 26, 2025
Shares owned after24,484
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
Transaction made pursuant to Mr. Atkinson's company approved trading plan under Rule 10b5-1, which was entered into on 02/22/2024.